Amoxicillin and Clavulanate Potassium Granule

Category:Finished Dosage > Antibiotics and Antiviral Preparations
Product Name:Amoxicillin and Clavulanate Potassium Granule
Price(USD):0.00
Company:Jiangsu Simcere Pharmaceutical Co., Ltd.

Basic Info
  • Factory Location: Simcere(Hainan)

    Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

  • Monthly Production Capacity: 100, 000, 000

    Packaging Information: Box Carton

  • Sample Provided: no

    Payment Terms: 300,000 sachet

    Amoxicillin and Clavulanate Potassium Granules

     

    Generic name: Amoxicillin and Clavulanate Potassium Granules(4:1)
    Brand name: Anqi
    Composition:
    Amoxicillin :(2S,5,R,6,R)-6-[(,R)-(-)-2-amino-2-(p-hydroxyphenyl)acetamido]-3,3-dimethyl-7-oxo-4-thia-1-
    azabicyclo[3.2.0]heptane-2-carboxylic acid trihydrate
    Clavulanate potassium :(Z)(2R,5R)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]-heptane-2-
    carboxylate

    Chemical structure:
    Amoxicillin and Clavulanate Potassium Granule

     

    Molecular formula: C16H19N3O5S•3H2O,C8H8KNO5
    Molecular weight:419.45,237.25

    Description: Anqi is granular and powder; aromatic, sweet.
    Indications:This product is indicated  for the treatment of infections caused by sensitive bacteria, such as:
    1  Upper Respiratory Tract Infection: sinusitis, tonsillitis, pharyngitis ,etc.
    2  Lower Respiratory Tract infection: acute bronchitis, acute exacerbation of chronic bronchitis, pneumonia,
    lung abscess and complicated bronchial infection.
    3  Urinary Tract Infections: cystitis, urethritis, pyelonephritis, prostatitis, pelvic inflammatory disease, urinary
    tract infections caused by Neisseria gonorrhoeae and soft chancre.
    4  Skin and Soft Tissue Infections: boils, abscesses, cellulitis, wound infection, intra-abdominal sepsis etc.
    5  Other Infections: otitis media, osteomyelitis, septicemia, peritonitis and postoperative infection etc.

    Strength:156.25mg(4:1)
    Dosage and Administration:

    Taken orally.For adults and children more than 12 years old, 2 packets each time, 3 times daily; and for
    children between 7 to 12 years old, 1.5 packets each time, 3 times daily; and for children between 1 to7 years
    old,1 packet each time, 3 times daily; and for children between 3 months to 1 years old, 0.5 packet each time,
    3 times daily; In the case of  serious infection, the dose can be doubled or be followed the doctor's advice.
    Without re-examination, consecutive treatment period should be no more than 14 days.
    Pharmacology and toxicology:
    Mechanism of action:
    Adco-Amoclav is a combination of amoxicillin and potassium clavulanate. The amoxicillin component of the
    formulation exerts a bactericidal action against many strains of Gram positive and Gram-negative organisms.
    The clavulanic acid component has little or no antimicrobial action. However, by inactivation of susceptible
    beta-lactamase protect amoxicillin from degradation by beta-lactamase enzymes produced by penicillin
    resistant strains of organisms.
    Antibacterial Activity 
    Clavulanic acid is an irreversible inhibitor of beta-lactamases produced by Staphylococcus aureus,
    Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis and Proteus vulgaris , H. influenzae, N.
    gonorrhoeae and B. fragilis( In-vitroactivity does not necessarily imply in-vivo efficacy). Potassium clavulanate
    does not inactivate the chromosomally mediated (Cephalosporinase) beta-lactamases produced by Acineto
    bacter species, Citrobacter species,Enterobacter, indole positive Proteus, Providencia species and Serratia
    marcescens.
    Pharmacokinetics:
    The pharmacokinetics of amoxicillin and clavulanic acid are closely allied and neither are adversely affected
    by the presence of food in the stomach, and are stable in the presence of gastric acid. The oral bioavailability
    of amoxicillin and potassium clavulante is approximately 90% and 75% respectively.
    Peak serum levels of both occur about 1-2 hour after oral administration. Clavulanic acid has about the same
    plasma elimination half-life (1 hour) as that of amoxicillin (1,3 hours). Adco-Amoclav Suspension is eliminated
    primarily unchanged through the renal route (glomerularfiltration and tubular secretion). Approximately 50-78%
    of amoxicillin and 25-40% of clavulanic acid are excreted unchanged in urine within the first 6 hrs after
    administration.
    SIDE EFFECTS AND SPECIAL PRECAUTIONS:
    Side effects 
    Amoxicillin
    Sensitivity reactions are more likely to occur in individuals who have previously demonstrated hypersensitivity
    to penicillins and in those with a history of allergy, asthma, hay fever or urticaria.The hypersensitivity reactions
    reported are erythematous maculopapular rashes,  fever and joint pains. Anaphylactic shock may occur.
    Gastrointestinal
    Nausea, heartburn, vomiting and diarrhoea.
    Pseudomembranous colitis has been reported.
    Liver
    Hepatotoxicity, hepatitis, cholestatic jaundice may occur. A moderate rise in serum glutamic oxalacetic
    transaminase (SGOT) has been noted, but the significance of this finding is unknown.
    Hemic and Lymphatic Systems 
    Anaemia, thrombocytopenia, thrombocytopenic purpura, eosinophilia, leukopenia and granulocytopenia have
    been reported during therapy with Adco-Amoclav. These reactions are usually reversible on discontinuation
    of therapy and are believed to be hypersensitivity phenomena.
    Central Nervous System
    Reversible hyperactivity, agitation, anxiety, insomnia, confusion, behavioural changes, and/or dizziness have
    also been reported. Depression, seizures, or hallucinations.
    Other A sore mouth or tongue and a black hairy tongue have been reported.
    Allergic reactions which may include exfoliative dermatitis, other skin rashes, interstitial nephritis and
    vasculitis, may occur. Erythema multiforme (including Stevens Johnson syndrome), toxic episodes of
    necrolysis.

    Storage:Store below 25°C, protected from moisture.
    After reconstitution the product must be stored at 2-8°C in a refrigerator. In order to maintain stability,
    the prepared suspension must under no circumstances be stored outside the fridge.
    The prepared suspension should be consumed within 7 days of preparation.
    Packs:156.25mg /sachet,  6 sachets/Box
    Shelf-life:24 months 

                  

Send your message to this supplier
  • From:
  • To:
    Jiangsu Simcere Pharmaceutical Co., Ltd.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service